Natural health product · NPN 80116551
Edge
No: licence discontinued
The licence holder discontinued the product licence.
Licence status Discontinued; licensed February 18, 2022.
- Natural Product Number (NPN)
- 80116551
- Licence holder
- Plexus Canada Limited Partnership
- Dosage form
- Capsule
- Route
- Oral
- Licensing route
- General (non-traditional)
- First licensed
- February 18, 2022
Also sold as
Other product names on the same licence.
- Plexus Edge
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| 1,3,7-Trimethylxanthine | 90 mg | Coffea canephora - Seed |
| 1,3,7-Trimethylxanthine | 90 mg | Caffeine |
| 7,9-Dihydro-1,3,7,9-tetramethyl-1H-purine-2,6,8(3H)-trione | 125 mg | Theacrine |
| L-Theanine | 100 mg | L-Theanine |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- Helps to temporarily increase energy and to reduce fatigue. Helps support cognitive performance. Helps to temporarily improve sustained attention. Helps to temporarily improve sustained attention in 60 minutes. Helps to temporarily support sustained attention. Helps to temporarily improve mental alertness. Helps to temporarily promote mental focus.
Non-medicinal ingredients
Hypromellose; Magnesium stearate; Microcrystalline cellulose; Calcium silicate; Silicon dioxide